One-Year Prognosis Difference of Myocardial Infarction With or Without Coronary Obstruction in Developing Countries:

Amine Bouchlarhem1,2, Ihssane Merimi1,2, Zakaria Bazid1,2

  • 1Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.

Insights

Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) have a better prognosis than those with Myocardial Infarction with Coronary Artery Disease (MI-CAD). MINOCA patients experienced lower rates of mortality and acute events over one year.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Cardiovascular Research

Background:

  • Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) diagnosis presents diagnostic challenges.
  • The comparative prevalence of mortality and acute events between MINOCA and Myocardial Infarction with Coronary Artery Disease (MI-CAD) remains debated.

Purpose of the Study:

  • To compare the clinical and prognostic characteristics of MINOCA patients versus MI-CAD patients.
  • To evaluate 1-year all-cause mortality and a composite of 1-year readmission for myocardial infarction or acute heart failure as primary and secondary outcomes.

Main Methods:

  • A 2-year retrospective study of patients admitted for Acute Coronary Syndrome (ACS).
  • Analysis of 1077 patients, categorizing them into MINOCA (4.7%) and MI-CAD (95.3%) groups.
  • Statistical comparison of baseline characteristics and 1-year outcomes, including mortality and readmission rates.

Main Results:

  • Significant differences observed in age, hypertension, diabetes, and ejection fraction between MINOCA and MI-CAD groups.
  • MINOCA patients demonstrated a significantly better prognosis.
  • Adjusted hazard ratios indicated lower 1-year mortality (HR=0.601), ACS readmission (HR=0.662), and AHF readmission (HR=0.539) in MINOCA patients.

Conclusions:

  • Despite etiological uncertainties, MINOCA patients exhibit a favorable short- and long-term prognosis.
  • MINOCA is associated with significantly better outcomes compared to MI-CAD.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary SyndromeI: Introduction01:30

Acute Coronary SyndromeI: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
15
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3